Literature DB >> 22175825

Potent inhibitors of LpxC for the treatment of Gram-negative infections.

Matthew F Brown1, Usa Reilly, Joseph A Abramite, Joel T Arcari, Robert Oliver, Rose A Barham, Ye Che, Jinshan Michael Chen, Elizabeth M Collantes, Seung Won Chung, Charlene Desbonnet, Jonathan Doty, Matthew Doroski, Juntyma J Engtrakul, Thomas M Harris, Michael Huband, John D Knafels, Karen L Leach, Shenping Liu, Anthony Marfat, Andrea Marra, Eric McElroy, Michael Melnick, Carol A Menard, Justin I Montgomery, Lisa Mullins, Mark C Noe, John O'Donnell, Joseph Penzien, Mark S Plummer, Loren M Price, Veerabahu Shanmugasundaram, Christy Thoma, Daniel P Uccello, Joseph S Warmus, Donn G Wishka.   

Abstract

In this paper, we present the synthesis and SAR as well as selectivity, pharmacokinetic, and infection model data for representative analogues of a novel series of potent antibacterial LpxC inhibitors represented by hydroxamic acid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22175825     DOI: 10.1021/jm2014748

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.

Authors:  Meritxell García-Quintanilla; José M Caro-Vega; Marina R Pulido; Patricia Moreno-Martínez; Jerónimo Pachón; Michael J McConnell
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Structural basis of the promiscuous inhibitor susceptibility of Escherichia coli LpxC.

Authors:  Chul-Jin Lee; Xiaofei Liang; Ramesh Gopalaswamy; Javaria Najeeb; Eugene D Ark; Eric J Toone; Pei Zhou
Journal:  ACS Chem Biol       Date:  2013-10-31       Impact factor: 5.100

4.  LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents.

Authors:  Haruaki Kurasaki; Kosuke Tsuda; Mariko Shinoyama; Noriko Takaya; Yuko Yamaguchi; Ryuta Kishii; Kazuhiko Iwase; Naoki Ando; Masahiro Nomura; Yasushi Kohno
Journal:  ACS Med Chem Lett       Date:  2016-04-05       Impact factor: 4.345

5.  Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.

Authors:  Kerry E Murphy-Benenato; Nelson Olivier; Allison Choy; Philip L Ross; Matthew D Miller; Jason Thresher; Ning Gao; Michael R Hale
Journal:  ACS Med Chem Lett       Date:  2014-09-23       Impact factor: 4.345

Review 6.  Translational deficiencies in antibacterial discovery and new screening paradigms.

Authors:  Paul M Dunman; Andrew P Tomaras
Journal:  Curr Opin Microbiol       Date:  2015-09-08       Impact factor: 7.934

Review 7.  Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.

Authors:  Alice L Erwin
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

8.  In Vitro and In Vivo Efficacy of an LpxC Inhibitor, CHIR-090, Alone or Combined with Colistin against Pseudomonas aeruginosa Biofilm.

Authors:  Jun Hou Tan; Celine Vidaillac; Joey Kuok Hoong Yam; Song Lin Chua; Michael Givskov; Liang Yang
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 9.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

10.  Mutants resistant to LpxC inhibitors by rebalancing cellular homeostasis.

Authors:  Daina Zeng; Jinshi Zhao; Hak Suk Chung; Ziqiang Guan; Christian R H Raetz; Pei Zhou
Journal:  J Biol Chem       Date:  2013-01-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.